MedTrace Logo

Epidemiology Study in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer

NCT01208779 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2013-07-17

No results posted yet for this study

Summary

This observational study in estrogen receptor positive early breast cancer patients is aimed to evaluate the patients' compliance to aromatase inhibitor (AI) therapy and to collect country-specific data in estrogen receptor positive early breast cancer patients including data on demography, disease characteristics and disease management.

Conditions

  • Hormon Receptor Positive Breast Cancer

Sponsors & Collaborators

Principal Investigators

  • Dr Jasna Pesic · M.D.spec of oncology, Institute for oncology Vojvodina, Sremska Kamenica

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • Serbia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01208779 on ClinicalTrials.gov